The meta-analysis revealed significant reductions in markers such as high-sensitivity C-reactive protein (his-CRP), interleukin (IL)-6, and plasma glucose, along with improvements in Flow-Mediated Dilation (FMD) and diastolic blood pressure after periodontitis treatment. The gene discussed is IL6; the disease is periodontitis.